Annexon (ANNX) Competitors $2.96 +0.15 (+5.16%) Closing price 07/3/2025 03:49 PM EasternExtended Trading$2.96 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANNX vs. PAHC, BGM, ABCL, WVE, VERV, ELVN, NTLA, AKBA, COLL, and ARDXShould you be buying Annexon stock or one of its competitors? The main competitors of Annexon include Phibro Animal Health (PAHC), BGM Group (BGM), AbCellera Biologics (ABCL), WAVE Life Sciences (WVE), Verve Therapeutics (VERV), Enliven Therapeutics (ELVN), Intellia Therapeutics (NTLA), Akebia Therapeutics (AKBA), Collegium Pharmaceutical (COLL), and Ardelyx (ARDX). These companies are all part of the "pharmaceutical products" industry. Annexon vs. Its Competitors Phibro Animal Health BGM Group AbCellera Biologics WAVE Life Sciences Verve Therapeutics Enliven Therapeutics Intellia Therapeutics Akebia Therapeutics Collegium Pharmaceutical Ardelyx Annexon (NASDAQ:ANNX) and Phibro Animal Health (NASDAQ:PAHC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership. Which has more volatility and risk, ANNX or PAHC? Annexon has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Phibro Animal Health has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Do institutionals and insiders hold more shares of ANNX or PAHC? 99.3% of Phibro Animal Health shares are held by institutional investors. 11.9% of Annexon shares are held by company insiders. Comparatively, 50.1% of Phibro Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is ANNX or PAHC more profitable? Phibro Animal Health has a net margin of 2.68% compared to Annexon's net margin of 0.00%. Phibro Animal Health's return on equity of 30.51% beat Annexon's return on equity.Company Net Margins Return on Equity Return on Assets AnnexonN/A -54.45% -46.56% Phibro Animal Health 2.68%30.51%6.89% Which has stronger valuation and earnings, ANNX or PAHC? Phibro Animal Health has higher revenue and earnings than Annexon. Annexon is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnnexonN/AN/A-$138.20M-$1.18-2.50Phibro Animal Health$1.02B1.11$2.42M$0.7835.88 Do analysts prefer ANNX or PAHC? Annexon currently has a consensus price target of $12.50, suggesting a potential upside of 323.01%. Phibro Animal Health has a consensus price target of $21.80, suggesting a potential downside of 22.12%. Given Annexon's stronger consensus rating and higher probable upside, equities research analysts plainly believe Annexon is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Annexon 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Phibro Animal Health 2 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Does the media refer more to ANNX or PAHC? In the previous week, Phibro Animal Health had 2 more articles in the media than Annexon. MarketBeat recorded 5 mentions for Phibro Animal Health and 3 mentions for Annexon. Annexon's average media sentiment score of 1.57 beat Phibro Animal Health's score of 0.23 indicating that Annexon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Annexon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Phibro Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPhibro Animal Health beats Annexon on 10 of the 15 factors compared between the two stocks. Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANNX vs. The Competition Export to ExcelMetricAnnexonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$317.08M$2.91B$5.54B$9.05BDividend YieldN/A2.44%5.24%4.02%P/E Ratio-2.5021.5627.4320.23Price / SalesN/A281.76422.11118.64Price / CashN/A42.7336.8958.07Price / Book1.077.518.045.67Net Income-$138.20M-$55.05M$3.18B$249.13M7 Day Performance22.61%4.61%2.89%3.28%1 Month Performance15.88%4.72%3.70%5.56%1 Year Performance-34.19%5.92%36.15%21.12% Annexon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANNXAnnexon2.3066 of 5 stars$2.96+5.2%$12.50+323.0%-38.4%$317.08MN/A-2.5060PAHCPhibro Animal Health3.6455 of 5 stars$25.54-0.5%$21.80-14.6%+63.3%$1.04B$1.02B32.741,940BGMBGM GroupN/A$10.59-11.5%N/AN/A$1.03B$25.10M0.00298ABCLAbCellera Biologics2.4886 of 5 stars$3.43-5.0%$8.33+143.0%+40.4%$1.02B$28.83M-6.12500High Trading VolumeWVEWAVE Life Sciences4.3732 of 5 stars$6.50-2.5%$20.50+215.4%+31.0%$1.01B$104.94M-7.74240VERVVerve Therapeutics3.4509 of 5 stars$11.23-0.6%$14.57+29.8%+118.4%$1.00B$32.33M-5.32110ELVNEnliven Therapeutics2.5174 of 5 stars$20.06-3.0%$39.60+97.4%-4.1%$984.34MN/A-10.4550Analyst ForecastAnalyst RevisionNTLAIntellia Therapeutics4.7211 of 5 stars$9.38-1.9%$33.37+255.7%-53.3%$971.61M$45.57M-1.79600News CoverageAKBAAkebia Therapeutics4.2715 of 5 stars$3.64-0.3%$6.75+85.4%+280.9%$956.00M$184.91M-17.33430Insider TradeCOLLCollegium Pharmaceutical4.2257 of 5 stars$29.57-1.2%$43.75+48.0%-6.1%$950.08M$631.45M24.24210News CoverageAnalyst DowngradeARDXArdelyx4.4484 of 5 stars$3.92+6.2%$10.89+177.8%-19.3%$937.90M$333.61M-17.8290 Related Companies and Tools Related Companies PAHC Competitors BGM Competitors ABCL Competitors WVE Competitors VERV Competitors ELVN Competitors NTLA Competitors AKBA Competitors COLL Competitors ARDX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANNX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
